RS
TNYA icon

R Squared’s Tenaya Therapeutics TNYA Stock Holding History

R Squared’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.76K Buy
+11,208
New +$8.27K ﹤0.01% 475

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

R Squared's TNYA Position: Q1 2026 in Review

R Squared opened a new position in Tenaya Therapeutics (TNYA) in Q1 2026: 11,208 shares worth $7.76K. The stake represents ﹤0.01% of the portfolio and ranks #475 among its holdings.

103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • R Squared held 11,208 shares of Tenaya Therapeutics worth $7.76K as of Q1 2026.
  • Tenaya Therapeutics was a new R Squared position in Q1 2026.
  • Tenaya Therapeutics made up ﹤0.01% of R Squared's portfolio in Q1 2026, its #475 holding.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on R Squared's 13F filing for Q1 2026, filed 29 Apr 2026.